Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2021 Annual Meeting and Exposition was held in Atlanta on the 11-14 December. ASH has successfully honed the hybrid model and showcased outstanding leaps in understanding and treatment in 2021, across malignancies. Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
View all videos

ASH 2021

The 63rd ASH Annual Meeting and Exposition
11–14 December 2021 | Atlanta, GA

At #EHA2024, Umberto Vitolo (@fpoirccs) presented the first data from the R/R #FollicularLymphoma cohort of the EPCORE NHL-1 trial investigating epcoritamab.

Click here to watch our interview w/ Prof. Vitolo:
👉

#LYMsm #ImmunoOnc #HemOnc @EHA_Hematology

Image for twitter card

Epcoritamab in R/R FL: pooled efficacy data from EPCORE NHL-1

Umberto Vitolo, MD, Candiolo Cancer Institute, Turin, Italy, presents the pooled efficacy data from the relapsed/refract...

ow.ly

Proud to participate in 3 trials in #MPNsm that were among the top clinical trials presented at #EHA2024 : TRANSFORM-1 and MANIFEST-2 in myelofibrosis, and CONTINUATION-PV in polycythemia vera!

I am very happy to announce the acceptance of my application by the Specialized Working Group (SWG) Committee as a new member. I am fully committed with the @EHA_Hematology activities to serve our members and our #community in #hematology

Load More...

ASH 2021

The 63rd ASH Annual Meeting and Exposition
11–14 December 2021 | Atlanta, GA

Breaking Updates in Hematological-Oncology

The American Society of Hematology (ASH) 2021 Annual Meeting and Exposition was held in Atlanta on the 11-14 December. ASH has successfully honed the hybrid model and showcased outstanding leaps in understanding and treatment in 2021, across malignancies. Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
View all videos

At #EHA2024, Umberto Vitolo (@fpoirccs) presented the first data from the R/R #FollicularLymphoma cohort of the EPCORE NHL-1 trial investigating epcoritamab.

Click here to watch our interview w/ Prof. Vitolo:
👉

#LYMsm #ImmunoOnc #HemOnc @EHA_Hematology

Image for twitter card

Epcoritamab in R/R FL: pooled efficacy data from EPCORE NHL-1

Umberto Vitolo, MD, Candiolo Cancer Institute, Turin, Italy, presents the pooled efficacy data from the relapsed/refract...

ow.ly

Proud to participate in 3 trials in #MPNsm that were among the top clinical trials presented at #EHA2024 : TRANSFORM-1 and MANIFEST-2 in myelofibrosis, and CONTINUATION-PV in polycythemia vera!

I am very happy to announce the acceptance of my application by the Specialized Working Group (SWG) Committee as a new member. I am fully committed with the @EHA_Hematology activities to serve our members and our #community in #hematology

Load More...

post-ASH 2021 iwAL Virtual Workshop - apply for registration

Register for the post-ASH 2021 iwMPNs Virtual Workshop